Literature DB >> 2303325

Smooth muscle-derived factor stimulates mobility of human tumor cells.

E M Rosen1, L Meromsky, E Setter, D W Vinter, I D Goldberg.   

Abstract

Invasion of normal tissues is a complex process which requires active locomotion of malignant cells. Recent studies have identified a group of proteins which appear to be specific regulators of cell movement. Various strains and lines of fibroblast-like and vascular smooth muscle cells release into culture medium a unique protein activity which causes contiguous sheets of normal epithelial cells (e.g., Madin-Darby canine kidney, MDCK, cells) to spread and separate into individual cells (i.e., to scatter). Crude conditioned medium and partially purified MDCK scattering activity derived from human iliac artery smooth muscle cells (HIAS) scattered several lines of human squamous carcinoma cells (FaDu and A253) and markedly stimulated migration of carcinoma cells out of multicellular spheroids onto plastic culture surfaces. The scattering activities for MDCK and carcinoma cells showed similar sensitivities to temperature, trypsin treatment, and alteration of pH; both activities were blocked in the presence of cycloheximide. Unlike HIAS-derived factor, a similar MDCK scattering factor derived from ras-transformed NIH 3T3 cells did not scatter human carcinoma cells. These findings indicate that specific normal tissue-derived proteins may affect the mobility of tumor cells. Further studies of such proteins may yield insights into the mechanisms of tumor cell locomotion and tumor invasion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303325

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  15 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations.

Authors:  Y Yao; L Jin; A Fuchs; A Joseph; H M Hastings; I D Goldberg; E M Rosen
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 3.  Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.

Authors:  Roger Abounader; John Laterra
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

4.  Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.

Authors:  J Y Ljubimova; L M Petrovic; N Arkadopoulos; P Blanc; S A Geller; A A Demetriou
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

5.  Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line.

Authors:  J Gavrilović; G Moens; J P Thiery; J Jouanneau
Journal:  Cell Regul       Date:  1990-12

Review 6.  Protein factors which regulate cell motility.

Authors:  E M Rosen; I D Goldberg
Journal:  In Vitro Cell Dev Biol       Date:  1989-12

7.  Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.

Authors:  S Rong; M Bodescot; D Blair; J Dunn; T Nakamura; K Mizuno; M Park; A Chan; S Aaronson; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

Authors:  A B Tuck; M Park; E E Sterns; A Boag; B E Elliott
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

9.  Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells.

Authors:  A J Ridley; P M Comoglio; A Hall
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells.

Authors:  Y Li; M M Bhargava; A Joseph; L Jin; E M Rosen; I D Goldberg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-02       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.